Investor Presentaiton
MAX
P&L statement for the network
Healthcare
FY19
FY20
FY21
Figs in INR Cr
Change
Amount
% NR
Amount
% NR
Amount
% NR
over LY
Gross revenue (inc. movement in unbilled)
3,920
4,356
3,881
(10.9%)
Net revenue
3,599
100.0%
4,023
100.0%
3,629
100.0%
(9.8%)
Direct costs
1,566
43.5%
1,715
42.6%
1,508
41.6%
(12.0%)
Contribution
2,033
56.5%
2,308
57.4%
2,121
58.4%
(8.1%)
Indirect overheads
1,685
46.8%
1,719
42.7%
1,485
40.9%
(13.6%)
Operating EBITDA (post Ind AS-116)
348
9.7%
590
14.7%
636
17.5%
7.9%
Loss on fair valuation of pre-merger holding of Radiant
196
5.4%
under IND AS 103
Transaction cost
30
0.8%
43
1.1%
48
1.3%
10.8%
ESOP (Equity settled scheme)
27
0.7%
One time policy harmonization impact
5
0.1%
Movement in fair value of contingent consideration
19
0.5%
(3)
(0.1%)
0.0%
and amortisation of contract assets
Reported EBITDA
299
8.3%
549
13.6%
359
9.9%
(34.7%)
Finance cost (net)
155
4.3%
215
5.3%
187
5.2%
(12.9%)
Depreciation and amortisation
186
5.2%
208
5.2%
216
6.0%
3.6%
Profit before tax
(42)
(1.2%)
126
3.1%
(45)
(1.2%)
Tax
18
Profit after tax
(60)
0.5%
(1.7%)
(3)
(0.1%)
50
1.4%
129
3.2%
(95)
(2.6%)
Note:
2.
3.
1. The numbers for the previous period have been recasted and regrouped to match with the disclosure in the current period
FY19 financials are pre-IND AS -116 unaudited numbers based on arithmetic total of line items appearing in the pre-merger P&L of Max Healthcare and Radiant Lifecare
Operating EBITDA (pre Ind AS-116) stood at INR 548 Cr in FY20 and INR 601 Cr in FY21
27View entire presentation